U.S. FDA approves ScPharmaceuticals' heart failure therapy
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JPYRWVWGNBJDPDJJKTUFIEABKA.jpg)
The U.S. Food and Drug Administration on Monday approved ScPharmaceuticals Inc's therapy for patients with chronic heart failure.
Monday, October 10, 2022 at 2:43 pm